These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1017983)

  • 21. [Severe hepatotoxicity of tuberculostatic agents. Increase in the incidence].
    Moitinho E; Salmerón JM; Mas A; Bruguera M; Rodés J
    Gastroenterol Hepatol; 1996 Nov; 19(9):448-51. PubMed ID: 8998667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifampicin hepatitis. A clinical and histological study.
    Scheuer PJ; Summerfield JA; Lal S; Sherlock S
    Lancet; 1974 Mar; 1(7855):421-5. PubMed ID: 4131429
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination].
    Rossolini A; Cellesi C; Debolini A
    Farmaco Prat; 1973 Jun; 28(6):345-55. PubMed ID: 4714054
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Icterigenic hepatitis during the treatment with combined isoniazid and rifampicin. Clinical and experimental observations].
    Marche J; Hugues FC; Graisely B; Marche C
    Rev Tuberc Pneumol (Paris); 1971; 35(1):55-76. PubMed ID: 5559725
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic dysfunction in undernourished patients receiving isoniazid and rifampicin.
    Krishnaswamy K; Prasad CE; Murthy KJ
    Trop Geogr Med; 1991; 43(1-2):156-60. PubMed ID: 1750106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatotoxicity of rifampicin and isoniazid in children.
    Casteels-Van Daele M; Igodt-Ameye L; Corbeel L; Eeckels R
    J Pediatr; 1975 May; 86(5):739-41. PubMed ID: 1079531
    [No Abstract]   [Full Text] [Related]  

  • 31. [Icterus caused by rifampicin and isoniazide].
    Haber I; Hubens H; Buyssens N
    Tijdschr Gastroenterol; 1974; 17(3):165-76. PubMed ID: 4454055
    [No Abstract]   [Full Text] [Related]  

  • 32. [Liver tolerance of antitubercular treatment including rifampicin. Study on 214 cases].
    Decroix G; Pujet JC
    Sem Hop; 1973 Jun; 49(30):2219-24. PubMed ID: 4354303
    [No Abstract]   [Full Text] [Related]  

  • 33. [Increase in transaminases and jaundice during treatment with rifampicin combined with isoniazid].
    Kreis B; Boutonnet G
    Rev Tuberc Pneumol (Paris); 1970 Dec; 34(8):1097-106. PubMed ID: 5517156
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].
    Derveaux L; Demedts M; Fevery J; Gyselen A
    Ned Tijdschr Geneeskd; 1980 Jun; 124(25):1008-12. PubMed ID: 7402377
    [No Abstract]   [Full Text] [Related]  

  • 35. Antituberculous therapy and acute liver failure.
    Janes SL; Behrens J
    Lancet; 1995 Apr; 345(8953):867. PubMed ID: 7898259
    [No Abstract]   [Full Text] [Related]  

  • 36. [Light and electron microscopy studies of the liver in tuberculosis patients receiving rifampin and isoniazid].
    Pilheu JA; de Salvo MC; Koch O; Barcat JA
    Medicina (B Aires); 1981; 41(4):439-45. PubMed ID: 7339434
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
    Skakun NP; Tabachuk OE
    Probl Tuberk; 1991; (10):77-9. PubMed ID: 1788241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Jaundice and cytolysis in patients receiving rifampicin and isoniazid at the same time].
    Morère P; Stain JP; Bourreille J; Nouvet G
    Rev Tuberc Pneumol (Paris); 1970 Dec; 34(8):1110-9. PubMed ID: 5517158
    [No Abstract]   [Full Text] [Related]  

  • 39. [Fatal liver cell necrosis following short-term administration of isoniazid and rifampicin to a patient already under treatment with antiepileptics].
    Lenders JW; Bartelink AK; van Herwaarden CL; van Haelst UJ; van Tongeren JH
    Ned Tijdschr Geneeskd; 1983 Mar; 127(10):420-3. PubMed ID: 6835412
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.
    Farrell FJ; Keeffe EB; Man KM; Imperial JC; Esquivel CO
    Dig Dis Sci; 1994 Oct; 39(10):2255-9. PubMed ID: 7924752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.